LAS VEGAS, NV
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)HEMOSTASIS AND THROMBOSIS CENTER OF NEVADA, founded in 2017, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $24.1M in total revenue in fiscal year 2023. Expenses of $23.3M left a modest 3% surplus.
THE PRIMARY PURPOSE OF THE ORGANIZATION IS TO PROVIDE COMPREHENSIVE CLINICAL CARE TO PERSONS AFFECTED BY INHERITED BLOOD DISORDERS AND TO ADMINISTER PROGRAMS SUPPORTED BY FEDERAL GRANTS AWARDED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH RESOURCES SERVICES ADMINISTRATION (HRSA) AND BY THE CENTERS OF DISEASE CONTROL (CDC), INCLUDING GRANTS RELATED TO HEMOPHILIA AND SICKLE CELL DISEASE.
THE CENTER PROVIDES CARE TO PERSONS AFFECTED BY INHERITED BLOOD DISORDERS REGARDLESS OF THE INDIVIDUAL'S ABILITY TO PAY. THIS CENTER UTILIZES A COMPREHENSIVE CARE MODEL FOLLOWED BY HEMOPHILIA...
THE CENTER PROVIDES CARE TO PERSONS AFFECTED BY INHERITED BLOOD DISORDERS REGARDLESS OF THE INDIVIDUAL'S ABILITY TO PAY. THIS CENTER UTILIZES A COMPREHENSIVE CARE MODEL FOLLOWED BY HEMOPHILIA TREATMENT CENTERS (HTCS) ACROSS THE COUNTRY FOR OVER THIRTY YEARS. THE MODEL INVOLVES AN INTERDISCIPLINARY APPROACH TO THE CARE OF THE PATIENT. WHEN A PATIENT COMES IN FOR A COMPREHENSIVE VISIT, THEY ARE SEEN BY A CLINICAL TEAM CONSISTING OF A HEMATOLOGIST, NURSE PRACTITIONER, (OR PHYSICIAN ASSISTANT) A NURSE, A PHYSICAL THERAPIST (IF NECESSARY) AND A SOCIAL WORKER. THE CENTER IS WELL SUITED TO CARRY OUT THIS FUNCTION GIVEN THAT ITS CORE TEAM HAS BEEN INVOLVED IN THE CARE AND MANAGEMENT OF THESE PATIENTS FOR OVER TWENTY YEARS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $24,054,246 | $24,043,563 | +0.0% |
| Expenses | $23,311,713 | $23,248,064 | +0.0% |
| Net Income | $742,533 | $795,499 | -0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| CRAIG FOREMAN | EXECUTIVE DI | 40.00 |
Officer
|
$211,582 | $22,216 | $233,798 |
| ALISON BARTKO | DIRECTOR OF | 40.00 |
Highest
|
$154,434 | $26,381 | $180,815 |
| NIK ABDUL RASHID | PHYSICIAN | 40.00 |
Highest
|
$142,336 | $14,232 | $156,568 |
| REBECCA BERKOWITZ | PROGRAM DIRE | 40.00 |
Highest
|
$130,000 | $18,940 | $148,940 |
| DWIGHT GENEROSO | NURSE PRACTI | 40.00 |
Highest
|
$119,423 | $0 | $119,423 |
| JEFF NELSON | NURSE MANAGE | 40.00 |
Highest
|
$109,797 | $9,394 | $119,191 |
| JERRY FOX | CFO | 40.00 |
Officer
|
$94,231 | $15,704 | $109,935 |
| MIKE USGAARD | BOARD ADVISO | 40.00 |
Officer
|
$44,000 | $77 | $44,077 |
| WILLIAM SCOTT KENDRICK | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STUART RICHEY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JULIE USGAARD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KELLI WALTERS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $24,054,246 | $23,311,713 | $10,425,520 | $742,533 |
| 2023 | $24,043,563 | $23,248,064 | $9,893,285 | $795,499 |
| 2022 | $23,289,804 | $22,333,599 | $8,050,475 | $956,205 |
| 2021 | $20,976,394 | $19,055,209 | $7,461,927 | $1,921,185 |
| 2020 | $13,708,896 | $12,652,633 | $4,527,496 | $1,056,263 |
| 2019 | $10,838,277 | $9,460,254 | $2,646,943 | $1,378,023 |
Compare HEMOSTASIS AND THROMBOSIS CENTER OF NEVADA with other nonprofits in Nevada and across the country.